BioCentury
ARTICLE | Politics & Policy

FDA shutdown reprieve, but effects linger

January 25, 2019 11:08 PM UTC

FDA is poised to reopen with full staffing Monday following the announcement Friday afternoon that congressional Democrats had reached a deal with President Donald Trump. The deal will fund all government operations at FY18 levels for three weeks.

FDA is expected to accept new drug applications again, and is likely to meet PDUFA goals for NDAs and BLAs that are filed next week...